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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPERHeart Failure in Latin America 949
Edimar Alcides Bocchi, Alexandra Arias, Hugo Verdejo, Mirta Diez, Efraín Gómez, Pablo Castro,
for the Interamerican Society of Cardiology
In this state-of-the-art paper, Bocchi and colleagues review the literature including data from
the World Health Organization, a recent registry from Latin American countries, and
epidemiological studies to provide the current status of heart failure (HF) in Latin America
(LA). The study reveals that the main etiology of HF in LA by country include idiopathic
dilated cardiomyopathy (from 1.3% to 37%), Chagas disease (from 1.3% to 21%), ischemic
(from 17% to 68%), systemic arterial hypertension (from 14% to 76%), valvular (3% to 22%),
and alcohol (from 1.1% to 8%). Decompensated HF is the main cause of cardiovascular
hospitalizations, and the prevalence of systolic HF varies from 64% to 69%. The authors
conclude that in addition to an increase in traditional heart failure risk factors, LA has the
additional burden of Chagas disease and rheumatic heart disease with a lower total
expenditure of health per capita.CLINICAL RESEARCH CORONARY ARTERY DISEASERBBB (Not LBBB) and Large Anteroseptal Scar 959
David G. Strauss, Zak Loring, Ronald H. Selvester, Gary Gerstenblith, Gordon Tomaselli,
Robert G. Weiss, Galen S. Wagner, Katherine C. Wu
In a cohort of chronic ischemic and nonischemic cardiomyopathy patients, Strauss and
colleagues use cardiac magnetic resonance (CMR) with late gadolinium enhancement (LGE)
to test the hypothesis that right bundle branch block (RBBB) patients have larger scar burden
than left bundle branch (LBBB) patients. Electrocardiograms and CMR-LGE were
performed in 233 patients with left ventricular ejection fraction 35% receiving primary
prevention implantable deﬁbrillators. A second cohort of 20 hypertrophic cardiomyopathy
patients undergoing alcohol septal ablation were studied. In the implantable cardioverter-
deﬁbrillator cohort, RBBB patients had signiﬁcantly larger scar size (24% vs. 65%, p < 0.001)
and were more likely to have ischemic heart disease (79% vs. 29%, p < 0.001) as compared
with LBBB patients. In the alcohol septal ablation cohort, 15 of 20 (75%) developed RBBB
post-ablation but no patient developed LBBB. The authors concluded that in patients with
left ventricular ejection fraction 35%, RBBB is associated with signiﬁcantly greater scar size
than LBBB and occlusion of the proximal left anterior descending septal perforator causes
RBBB. In contrast, LBBB is most commonly caused by nonischemic pathologies.
Editorial Comment: Toby R. Engel, Nelson M. Wolf, p. 968(continued on page A-22)
SEPTEMBER 10, 2013 (continued) A-22CORONARY ARTERY DISEASEPost-Traumatic Stress Disorder and Coronary Heart Disease 970
Viola Vaccarino, Jack Goldberg, Cherie Rooks, Amit J. Shah, Emir Veledar, Tracy L. Faber,
John R. Votaw, Christopher W. Forsberg, J. Douglas Bremner
This study investigates whether post-traumatic stress disorder (PTSD) is associated with
coronary heart disease (CHD). Male twins from the Vietnam Era Twin registry that were
discordant for a lifetime history of PTSD and major depression were studied. A total of
562 twins (281 pairs with mean age 42.6 years) were included. The incidence of CHD was
more than double in twins with PTSD (22.6%) than those without PTSD (8.9%, p < 0.001).
Stress total severity score from myocardial perfusion by positron emission tomography was
signiﬁcantly higher and coronary ﬂow reserve was lower in twins with PTSD than those
without. Vaccarino and colleagues conclude that among Vietnam era veterans, PTSD is a risk
factor for CHD.
Editorial Comment: Stephen Sidney, p. 979CORONARY ARTERY DISEASEMultiple Antithrombotic Treatment for AF Post AMI and PCI 981
Morten Lamberts, Gunnar H. Gislason, Jonas Bjerring Olesen, Søren Lund Kristensen,
Anne-Marie Schjerning Olsen, Anders Mikkelsen, Christine Benn Christensen, Gregory Y. H. Lip,
Lars Køber, Christian Torp-Pedersen, Morten Lock Hansen
Lamberts and colleagues investigate the risk of thrombosis and bleeding of multiple
antithrombotic treatment regimens in atrial ﬁbrillation (AF) patients post-myocardial
infarction (MI) or after undergoing percutaneous coronary intervention (PCI). A total of
12,165 AF patients hospitalized with MI or undergoing PCI were identiﬁed, and risk of
MI/coronary death, ischemic stroke, and bleeding according to antithrombotic treatment
regime was estimated. Within 1 year, MI or coronary death, ischemic stroke, and bleeding
events occurred in 2,255 (18.5%), 680 (5.6%), and 756 (6.3%) patients, respectively. Relative
to triple therapy (oral anticoagulation [OAC] + aspirin + clopidogrel), no increase in risk
of recurrent coronary event was seen for OAC + clopidogrel, OAC + aspirin, or aspirin +
clopidogrel, but aspirin + clopidogrel resulted in higher risk of ischemic stroke. When
compared to triple therapy, bleeding risks were nonsigniﬁcantly reduced for OAC +
clopidogrel and signiﬁcantly reduced for aspirin + clopidogrel. The authors conclude that
in real-life AF patients with indication for multiple antithrombotic therapy after MI/PCI,
OAC + clopidogrel was equal or better on both beneﬁt and safety outcomes compared with
triple therapy.
Editorial Comment: Steven M. Markowitz, p. 990(continued on page A-23)
SEPTEMBER 10, 2013 (continued) A-23BIOMARKERSRelease Kinetics of MicroRNAs 992
Christoph Liebetrau, Helge Möllmann, Oliver Dörr, Sebastian Szardien, Christian Troidl,
Matthias Willmer, Sandra Voss, Luise Gaede, Johannes Rixe, Andreas Rolf, Christian Hamm, Holger Nef
Liebetrau and colleagues analyze the ﬁrst-time release kinetics of muscle-enriched and
cardiac-speciﬁc microRNA, a potential biomarker in patients with acute myocardial
infarction (AMI). Release kinetics of circulating muscle-enriched miRNAs (miR-1, miR-21,
miR 208a, and miR 133a) were analyzed in 21 patients with hypertrophic obstructive
cardiomyopathy undergoing transcoronary ablation of septal hypertrophy. Circulating
concentration of miR-1 signiﬁcantly increased (>3-fold; p ¼ 0.01) after 15 min with peak
75 min after septal ablation. Concentration of miR-133a were signiﬁcantly increased at
15 min and reached a plateau between 75 min and 480 min (>50-fold change). The miR 208
concentrations were elevated at 105 min (>2-fold) without further increase. The authors
conclude that miR-1, miR 208a, and miR 133a continuously rose during the ﬁrst hours after
the induction of AMI and may be potentially useful as biomarkers in patients with acute
coronary syndrome.
Editorial Comment: Luigi M. Biasucci, Maria Teresa Cardillo, p. 999HEART VALVE DISEASEAortic Stenosis Epidemiology and TAVR Candidates 1002
Ruben L. J. Osnabrugge, Darren Mylotte, Stuart J. Head, Nicolas M. Van Mieghem, Vuyisile T. Nkomo,
Corinne M. LeReun, Ad J. J. C. Bogers, Nicolo Piazza, A. Pieter Kappetein
The objective of this study was to evaluate the prevalence of aortic stenosis (AS) in the elderly
and to estimate the current and future number of candidates for transcatheter aortic valve
replacement. Data from 7 studies were used (n ¼ 9,723). Monte Carlo simulations were
performed to estimate number of transcatheter aortic valve replacement (TAVR) candidates.
The pooled prevalence of severe AS in the elderly was 12.4%, while the prevalence of severe
AS was 3.4%. Among elderly patients with severe AS, 75.6% are symptomatic and 40.5% of
these patients are not treated surgically. Of the patients referred for TAVR that actually
received a transcatheter valve, the European pooled percentage was 40.3% and the U.S.
pooled percentage was 24.4%. Based on the data and estimates, the authors conclude that
there are currently approximately 190,000 and 100,000 TAVR candidates in European
countries and North America, respectively, and each year approximately 18,000 new TAVR
candidates emerge in European countries and 9,000 in North America.
Editorial Comment: Alec Vahanian, Bernard Iung, Dominique Himbert, p. 1013(continued on page A-24)
SEPTEMBER 10, 2013 (continued) A-24HEART RHYTHM DISORDERSElectrical Storms of Idiopathic VF and J Waves 1015
Yoshifusa Aizawa, Masaomi Chinushi, Kanae Hasegawa, Nobu Naiki, Minoru Horie, Yoshiaki Kaneko,
Masahiko Kurabayashi, Shogo Ito, Tsutomu Imaizumi, Yoshiyasu Aizawa, Seiji Takatsuki, Kunitake Joo,
Masahito Sato, Katsuya Ebe, Yukio Hosaka, Michel Haissaguerre, Keiichi Fukuda
The aim of this study was to characterize patients with idiopathic ventricular ﬁbrillation
(IVF) who develop electrical storm (ES). Electrocardiographic features of 91 IVF patients
with and without ES were studied. A total of 14 (15.4%) had VF occurring at out-of-hospital
at night or in early morning. J waves were more closely associated with VF storm compared
with patients without VF storm: 92.9% versus 27.1% (p < 0.001). VF storm was controlled
by intravenous isoproterenol, which attenuated the J-wave amplitude. The authors concluded
that VF storm in IVF patients was highly associated with J waves that showed augmentation
prior to VF. Isoproterenol was effective in controlling VF and attenuating J waves.
Subsequent antiarrhythmic therapy appeared to be effective for prophylaxis of VF.CONGENITAL DISEASECoarctation of the Aorta: Lifelong Surveillance 1020
Morgan L. Brown, Harold M. Burkhart, Heidi M. Connolly, Joseph A. Dearani, Frank Cetta,
Zhuo Li, William C. Oliver, Carole A. Warnes, Hartzell V. Schaff
The investigators review the long-term outcome of patients undergoing primary surgical
repair of isolated aortic coarctation. A total of 819 patients operated on between 1946 and
2005 were identiﬁed. Mean age at repair was 17.2  13.6 years. Actuarial survival was 93.3%,
86.4%, and 73.5% at 10, 20, and 30 years, respectively. Older age at repair (>20 years) and
pre-operative hypertension were associated with decreased survival (p < 0.001). Freedom
from reintervention on the descending aorta was 96.7%, 92.2%, and 89% at 10, 20, and
30 years of follow-up. The authors conclude that primary repair of isolated coarctation can be
performed with low mortality. However, long-term survival is reduced and many patients will
require further re-operation.
